-
1
-
-
58149120422
-
Heart disease and stroke statistics-2010 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
-
Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics-2010 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2010; 121:e1-e170.
-
(2010)
Circulation.
, vol.121
-
-
Lloyd-Jones, D.1
Adams, R.J.2
Brown, T.M.3
-
2
-
-
33644631485
-
Therapeutic effects of xanthine oxidase inhibitors:renaissance half a century after the discovery of allopurinol
-
Pacher P, Nivorozhkin A, Szabo C. Therapeutic effects of xanthine oxidase inhibitors:renaissance half a century after the discovery of allopurinol. Pharmacol Rev. 2006;58:87-114.
-
(2006)
Pharmacol Rev.
, vol.58
, pp. 87-114
-
-
Pacher, P.1
Nivorozhkin, A.2
Szabo, C.3
-
3
-
-
77953613668
-
Allopurinol for chronic stable angina: Old drug, new tricks?
-
Antony R, Dargie HJ. Allopurinol for chronic stable angina: Old drug, new tricks? Lancet. 2010;375:2126-2127.
-
(2010)
Lancet.
, vol.375
, pp. 2126-2127
-
-
Antony, R.1
Dargie, H.J.2
-
4
-
-
80051657256
-
A new anti-ischemic role for an old drug
-
Stone PH. A new anti-ischemic role for an old drug. J Am Coll Cardiol. 2011;58:829-830.
-
(2011)
J Am Coll Cardiol.
, vol.58
, pp. 829-830
-
-
Stone, P.H.1
-
5
-
-
47049099695
-
The role of urate and xanthine oxidase inhibitors in cardiovascular disease
-
DOI 10.1111/j.1527-3466.2007.00029.x
-
George J, Struthers AD. The role of urate and xanthine oxidase inhibitors in cardiovascular disease. Cardiovasc Ther. 2008;26:59-64. (Pubitemid 351421775)
-
(2008)
Cardiovascular Therapeutics
, vol.26
, Issue.1
, pp. 59-64
-
-
George, J.1
Struthers, A.D.2
-
6
-
-
0030573050
-
Oxy free radical system in heart failure and therapeutic role of oral vitamin E
-
Ghatak A, Brar MJ, Agarwal A, et al. Oxy free radical system in heart failure and therapeutic role of oral vitamin E. Int J Cardiol. 1996;57:119f-127f.
-
(1996)
Int J Cardiol.
, vol.57
-
-
Ghatak, A.1
Brar, M.J.2
Agarwal, A.3
-
7
-
-
0028913891
-
Relation of serum uric acid to mortality and ischemic heart disease. NHANES 1 Epidemiologic follow-up study
-
Freedman DS, Williamson DF, Gunter EW, et al. Relation of serum uric acid to mortality and ischemic heart disease. NHANES 1 Epidemiologic follow-up study. Am J Epidemiol. 1995;141:637-644.
-
(1995)
Am J Epidemiol.
, vol.141
, pp. 637-644
-
-
Freedman, D.S.1
Williamson, D.F.2
Gunter, E.W.3
-
8
-
-
77955729725
-
Effect of allopurinol in chronic kidney disease progression and cardiovascular risk
-
Goicoechea M, de Vinuesa SG, Verdalles U, et al. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol. 2010;5:1388-1393.
-
(2010)
Clin J Am Soc Nephrol.
, vol.5
, pp. 1388-1393
-
-
Goicoechea, M.1
De Vinuesa, S.G.2
Verdalles, U.3
-
9
-
-
0034630917
-
Serum uric acid and cardiovascular mortality: The NHANES I Epidemiologic Follow-up Study, 1971-1992
-
Fang J, Alderman MH. Serum uric acid and cardiovascular mortality: The NHANES I epidemiologic follow-up study, 1971-1972. JAMA. 2000;283: 2404-2410. (Pubitemid 30257539)
-
(2000)
Journal of the American Medical Association
, vol.283
, Issue.18
, pp. 2404-2410
-
-
Fang, J.1
Alderman, M.H.2
-
11
-
-
0027275518
-
Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia
-
Zavaroni I, Mazza S, Fantuzzi M, et al. Changes in insulin and lipid metabolism in males with asymptomatic hyperuricemia. J Intern Med. 1993; 234:25-30. (Pubitemid 23240554)
-
(1993)
Journal of Internal Medicine
, vol.234
, Issue.1
, pp. 25-30
-
-
Zavaroni, I.1
Mazza, S.2
Fantuzzi, M.3
Dall'Aglio, E.4
Bonora, E.5
Delsignore, R.6
Passeri, M.7
Reaven, G.M.8
-
12
-
-
0026325211
-
Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration
-
Facchini F, Chen YD, Hollenbeck CB, et al. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA. 1991;266:3008-3011.
-
(1991)
JAMA.
, vol.266
, pp. 3008-3011
-
-
Facchini, F.1
Chen, Y.D.2
Hollenbeck, C.B.3
-
16
-
-
0033529386
-
Serum uric acid and risk for cardiovascular disease and death: The Framingham heart study
-
Culleton BJ, Larson MG, Kannel WB, et al. Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study. Ann Intern Med. 1999;131:7-13. (Pubitemid 29310011)
-
(1999)
Annals of Internal Medicine
, vol.131
, Issue.1
, pp. 7-13
-
-
Culleton, B.F.1
Larson, M.G.2
Kannel, W.B.3
Levy, D.4
-
17
-
-
85047692424
-
Serum uric acid: Its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia
-
Klein R, Klein BE, Cornoni J, et al. Serum uric acid: Its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia. Arch Intern Med. 1973;132:401-410.
-
(1973)
Arch Intern Med.
, vol.132
, pp. 401-410
-
-
Klein, R.1
Klein, B.E.2
Cornoni, J.3
-
18
-
-
0024242538
-
Hyperuricaemia and risk of cardiovascular disease and overall death
-
Bengtsson C, Lapidus L, Stendahal C, et al. Hyperuricemia and risk of cardiovascular disease and overall death. Acta Med Scand. 1988;224:549-555. (Pubitemid 19028197)
-
(1988)
Acta Medica Scandinavica
, vol.224
, Issue.6
, pp. 549-555
-
-
Bengtsson, C.1
Lapidus, L.2
Stendahl, C.3
Waldenstrom, J.4
-
19
-
-
0024508912
-
Serum uric acid and 11.5-year mortality of middle-aged women
-
Levine W, Dyer AR, Shekelle RB, et al. Serum uric acid and 11.5-year mortality of middle-aged women. J Clin Epidemiol. 1989;42:257-267.
-
(1989)
J Clin Epidemiol.
, vol.42
, pp. 257-267
-
-
Levine, W.1
Dyer, A.R.2
Shekelle, R.B.3
-
20
-
-
34548142983
-
Independent impact of gout on mortality and risk for coronary heart disease
-
DOI 10.1161/CIRCULATIONAHA.107.703389, PII 0000301720070821000006
-
Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation. 2007;116:894-900. (Pubitemid 47300913)
-
(2007)
Circulation
, vol.116
, Issue.8
, pp. 894-900
-
-
Choi, H.K.1
Curhan, G.2
-
21
-
-
44349151051
-
Long-term cardiovascular mortality among middle-aged men with gout
-
DOI 10.1001/archinte.168.10.1104
-
Krishnan E, Svendsen K, Neaton JD, et al. MRFIT Research Group. Longterm cardiovascular mortality among middle-aged men with gout. Arch Intern Med. 2008;168:1104-1110. (Pubitemid 351749228)
-
(2008)
Archives of Internal Medicine
, vol.168
, Issue.10
, pp. 1104-1110
-
-
Krishnan, E.1
Svendsen, K.2
Neaton, J.D.3
Grandits, G.4
Kuller, L.H.5
-
22
-
-
39749157632
-
Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: A Preventive Cardiology Information System (PreCIS) database cohort study
-
DOI 10.1002/art.23121
-
Ioachimescu AG, Brennan DM, Hoar BM. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: A preventive cardiology information system (PreCIS) database cohort study. Arthritis Rheum. 2008;58:623-630. (Pubitemid 351294901)
-
(2008)
Arthritis and Rheumatism
, vol.58
, Issue.2
, pp. 623-630
-
-
Ioachimescu, A.G.1
Brennan, D.M.2
Hoar, B.M.3
Hazen, S.L.4
Hoogwerf, B.J.5
-
23
-
-
0035050346
-
Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension
-
Wang JG, Staessen JA, Fagard RH, et al. Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension. Hypertension. 2001;37:1069-1074. (Pubitemid 32304006)
-
(2001)
Hypertension
, vol.37
, Issue.4
, pp. 1069-1074
-
-
Wang, J.-G.1
Staessen, J.A.2
Fagard, R.H.3
Birkenhager, W.H.4
Gong, L.5
Liu, L.6
-
24
-
-
0033670512
-
Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: The PIUMA study
-
Verdecchia P, Schillaci G, Reboldi G, et al. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: The PIUMA study. Hypertension. 2000;36:1072-1078.
-
(2000)
Hypertension.
, vol.36
, pp. 1072-1078
-
-
Verdecchia, P.1
Schillaci, G.2
Reboldi, G.3
-
25
-
-
3242785541
-
Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: A prospective cohort study
-
DOI 10.1001/archinte.164.14.1546
-
Niskanen LK, Laaksonen DE, Nyyssonen K, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: A prospective cohort study. Arch Intern Med. 2004;164:1546-1551. (Pubitemid 38970476)
-
(2004)
Archives of Internal Medicine
, vol.164
, Issue.14
, pp. 1546-1551
-
-
Niskanen, L.K.1
Laaksonen, D.E.2
Nyyssonen, K.3
Alfthan, G.4
Lakka, H.-M.5
Lakka, T.A.6
Salonen, J.T.7
-
26
-
-
33751023105
-
Uric acid and xanthine oxidase: Future therapeutic targets in the prevention of cardiovascular disease?
-
Dawson J, Walters M. Uric acid and xanthine oxidase: Future therapeutic targets in the prevention of cardiovascular disease? Br J Clin Pharmacol. 2006;62:633.
-
(2006)
Br J Clin Pharmacol.
, vol.62
, pp. 633
-
-
Dawson, J.1
Walters, M.2
-
27
-
-
33747043614
-
Gout and the risk of acute myocardial infarction
-
DOI 10.1002/art.22014
-
Krishnan E, Baker JF, Furst DE, et al. Gout and the risk of acute myocardial infarction. Arthritis Rheum. 2006;54:2688-2696. (Pubitemid 44208638)
-
(2006)
Arthritis and Rheumatism
, vol.54
, Issue.8
, pp. 2688-2696
-
-
Krishnan, E.1
Baker, J.F.2
Furst, D.E.3
Schumacher, H.R.4
-
28
-
-
34548132096
-
Serum uric acid level and risk for peripheral arterial disease: Analysis of data from the multiple risk factor intervention trial
-
DOI 10.1177/0003319707303444
-
Baker JF, Schumacher HR, Krishnan E. Serum uric acid level and risk for peripheral arterial disease: Analysis of data from the multiple risk factor intervention trial. Angiology. 2007;58:450-457. (Pubitemid 47301052)
-
(2007)
Angiology
, vol.58
, Issue.4
, pp. 450-457
-
-
Baker, J.F.1
Schumacher, H.R.2
Krishnan, E.3
-
29
-
-
0038460302
-
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report
-
DOI 10.1001/jama.289.19.2560
-
Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289:2560-2572. (Pubitemid 37430158)
-
(2003)
Journal of the American Medical Association
, vol.289
, Issue.19
, pp. 2560-2572
-
-
Chobanian, A.V.1
Bakris, G.L.2
Black, H.R.3
Cushman, W.C.4
Green, L.A.5
Izzo Jr., J.L.6
Jones, D.W.7
Materson, B.J.8
Oparil, S.9
Wright Jr., J.T.10
Roccella, E.J.11
-
30
-
-
0037118660
-
AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases
-
DOI 10.1161/01.CIR.0000020190.45892.75
-
Pearson TA, Blair SN, Daniels SR, et al. AHA Guidelines for primary prevention of cardiovascular disease and stroke: 2002 update. Consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation. 2002;106:388-391. (Pubitemid 34778969)
-
(2002)
Circulation
, vol.106
, Issue.3
, pp. 388-391
-
-
Pearson, T.A.1
Blair, S.N.2
Daniels, S.R.3
Eckel, R.H.4
Fair, J.M.5
Fortmann, S.P.6
Franklin, B.A.7
Goldstein, L.B.8
Greenland, P.9
Grundy, S.M.10
Hong, Y.11
Miller, N.H.12
Lauer, R.M.13
Ockene, I.S.14
Sacco, R.L.15
Sallis Jr., J.F.16
Smith Jr., S.C.17
Stone, N.J.18
Taubert, K.A.19
-
31
-
-
22044438742
-
Antioxidant vitamins and enzymatic and synthetic oxygen-derived free-radical scavengers in the prevention and treatment of cardiovascular disease
-
In: Frishman WH, Sonnenblick EH, Sica DA, eds. 2nd ed. New York, NY: McGraw Hill
-
Frishman WH, Kruger NA, Nayak DU, Vakili BA. Antioxidant vitamins and enzymatic and synthetic oxygen-derived free-radical scavengers in the prevention and treatment of cardiovascular disease. In: Frishman WH, Sonnenblick EH, Sica DA, eds. Cardiovascular Pharmacotherapeutics. 2nd ed. New York, NY: McGraw Hill; 2003:407-427.
-
(2003)
Cardiovascular Pharmacotherapeutics
, pp. 407-427
-
-
Frishman, W.H.1
Kruger, N.A.2
Nayak, D.U.3
Vakili, B.A.4
-
32
-
-
0021984681
-
Oxygen-derived free radicals in post-ischemic tissue injury
-
McCord JM. Oxygen-derived free radicals in post-ischemic tissue injury. N Engl J Med. 1985;312:159.
-
(1985)
N Engl J Med.
, vol.312
, pp. 159
-
-
McCord, J.M.1
-
33
-
-
67449085150
-
Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress
-
George J, Struthers AD. Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress. Vasc Health Risk Manag. 2009;5: 265-272.
-
(2009)
Vasc Health Risk Manag.
, vol.5
, pp. 265-272
-
-
George, J.1
Struthers, A.D.2
-
34
-
-
0022502428
-
Xanthine oxidase: Biochemistry, distribution and physiology
-
Parks DA, Granger DN. Xanthine oxidase: Biochemistry, distribution and physiology. Acta Physiol Scand Suppl. 1986;548:87-99. (Pubitemid 16090301)
-
(1986)
Acta Physiologica Scandinavica
, vol.126
, Issue.SUPPL. 548
, pp. 87-99
-
-
Parks, D.A.1
Granger, D.N.2
-
35
-
-
0036085521
-
Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy
-
DOI 10.1067/mhj.2002.122122
-
Cicoira M, Zanolla L, Rossi A, et al. Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy. Am Heart J. 2002;143:1107-1111. (Pubitemid 34666905)
-
(2002)
American Heart Journal
, vol.143
, Issue.6
, pp. 1107-1111
-
-
Cicoira, M.1
Zanolla, L.2
Rossi, A.3
Golia, G.4
Franceschini, L.5
Brighetti, G.6
Zeni, P.7
Zardini, P.8
-
37
-
-
0021902541
-
Free radicals and myocardial ischemia: The role of xanthine oxidase
-
In: Harris P, Poole-Wilson PA, eds. New York, NY: Elsevier Science
-
McCord JM, Roy RS, Schaffer SW. Free radicals and myocardial ischemia: The role of xanthine oxidase. In: Harris P, Poole-Wilson PA, eds. Advances in Myocardiology. Vol. 5. New York, NY: Elsevier Science; 1985:183.
-
(1985)
Advances in Myocardiology.
, vol.5
, pp. 183
-
-
McCord, J.M.1
Roy, R.S.2
Schaffer, S.W.3
-
38
-
-
0032127726
-
Xanthine oxidase reaction with nitric oxide and peroxynitrite
-
DOI 10.1006/abbi.1998.0675
-
Houston M, Chumley P, Radi R, et al. Xanthine oxidase reaction with nitric oxide and peroxynitrite. Arch Biochem Biophys. 1998;355:1-8. (Pubitemid 28371145)
-
(1998)
Archives of Biochemistry and Biophysics
, vol.355
, Issue.1
, pp. 1-8
-
-
Houston, M.1
Chumley, P.2
Radi, R.3
Rubbo, H.4
Freeman, B.A.5
-
39
-
-
0024848058
-
Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow
-
Ambrosio G, Weisman HF, Mannisi JA, Becker LC. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation. 1989;80:1846-1861. (Pubitemid 20031716)
-
(1989)
Circulation
, vol.80
, Issue.6
, pp. 1846-1861
-
-
Ambrosio, G.1
Weisman, H.F.2
Mannisi, J.A.3
Becker, L.C.4
-
40
-
-
77953615298
-
Effect of high-dose allopurinol on exercise in patients with chronic stable angina: A randomised, placebo controlled crossover trial
-
Noman A, Ang DS, Ogston S, et al. Effect of high-dose allopurinol on exercise in patients with chronic stable angina: A randomised, placebo controlled crossover trial. Lancet. 2010;375:2161-2167.
-
(2010)
Lancet.
, vol.375
, pp. 2161-2167
-
-
Noman, A.1
Ang, D.S.2
Ogston, S.3
-
41
-
-
38148998838
-
Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular reninangiotensin system
-
Corry DB, Eslami P, Yamamoto K, et al. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular reninangiotensin system. J Hypertens. 2008;26:269-275.
-
(2008)
J Hypertens.
, vol.26
, pp. 269-275
-
-
Corry, D.B.1
Eslami, P.2
Yamamoto, K.3
-
42
-
-
34547733397
-
Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress
-
DOI 10.1152/ajpcell.00600.2006
-
Sautin YY, Nakagawa T, Zharikov S, et al. Adverse effects of the classical antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/ nitrosative stress. Am J Physiol Cell Physiol. 2007;293:C584-C596. (Pubitemid 47235197)
-
(2007)
American Journal of Physiology - Cell Physiology
, vol.293
, Issue.2
-
-
Sautin, Y.Y.1
Nakagawa, T.2
Zharikov, S.3
Johnson, R.J.4
-
43
-
-
33646748459
-
Uric acid and inflammatory markers
-
Ruggiero C, Cherubini A, Ble A, et al. Uric acid and inflammatory markers. Eur Heart J. 2006;27:1174-1181.
-
(2006)
Eur Heart J.
, vol.27
, pp. 1174-1181
-
-
Ruggiero, C.1
Cherubini, A.2
Ble, A.3
-
44
-
-
33645461474
-
Uric acid-induced C-reactive protein expression: Implication on cell proliferation and nitric oxide production of human vascular cells
-
Kang DH, Park SK, Lee IK, et al. Uric acid-induced C-reactive protein expression: Implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005;6:3553-3562.
-
(2005)
J Am Soc Nephrol.
, vol.6
, pp. 3553-3562
-
-
Kang, D.H.1
Park, S.K.2
Lee, I.K.3
-
45
-
-
57349084723
-
Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells
-
DOI 10.1152/ajpcell.00075.2008
-
Zharikov S, Krotova K, Hu H, et al. Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells. Am J Physiol Cell Physiol. 2008;295:C1183-C1190. (Pubitemid 352790338)
-
(2008)
American Journal of Physiology - Cell Physiology
, vol.295
, Issue.5
-
-
Zharikov, S.1
Krotova, K.2
Hu, H.3
Baylis, C.4
Johnson, R.J.5
Block, E.R.6
Patel, J.7
-
46
-
-
0001654669
-
Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
-
Suwaidi JA, Hamasaki S, Higano ST, et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000;101:948-954. (Pubitemid 30131694)
-
(2000)
Circulation
, vol.101
, Issue.9
, pp. 948-954
-
-
Suwaidi, J.A.1
Hamasaki, S.2
Higano, S.T.3
Nishimura, R.A.4
Holmes Jr., D.R.5
Lerman, A.6
-
47
-
-
0030728423
-
Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects
-
Hasdai D, Gibbons RJ, Holmes DR Jr, et al. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation. 1997;96:3390-3395. (Pubitemid 27513410)
-
(1997)
Circulation
, vol.96
, Issue.10
, pp. 3390-3395
-
-
Hasdai, D.1
Gibbons, R.J.2
Holmes Jr., D.R.3
Higano, S.T.4
Lerman, A.5
-
48
-
-
0037047070
-
Allopurinol improves endothelial dysfunction in chronic heart failure
-
DOI 10.1161/01.CIR.0000022140.61460.1D
-
Farquharson CA, Butler R, Hill A, et al. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation. 2002;106:221-226. (Pubitemid 34761303)
-
(2002)
Circulation
, vol.106
, Issue.2
, pp. 221-226
-
-
Farquharson, C.A.J.1
Butler, R.2
Hill, A.3
Belch, J.J.F.4
Struthers, A.D.5
-
49
-
-
0037031266
-
Prognostic value of coronary vascular endothelial dysfunction
-
DOI 10.1161/01.CIR.0000025404.78001.D8
-
Halcox JP, Schenke WH, Zalos G, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation. 2002;106:653-658. (Pubitemid 34851922)
-
(2002)
Circulation
, vol.106
, Issue.6
, pp. 653-658
-
-
Halcox, J.P.J.1
Schenke, W.H.2
Zalos, G.3
Mincemoyer, R.4
Prasad, A.5
Waclawiw, M.A.6
Nour, K.R.A.7
Quyyumi, A.A.8
-
50
-
-
0028961663
-
Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced ischemia
-
Zeiher AM, Krause T, Schachinger V, et al. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced ischemia. Circulation. 1995;91:2345-2352.
-
(1995)
Circulation.
, vol.91
, pp. 2345-2352
-
-
Zeiher, A.M.1
Krause, T.2
Schachinger, V.3
-
51
-
-
80051616824
-
Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris
-
Rajendra NS, Ireland S, George J, et al. Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris. J Am Coll Cardiol 2011;58:820-828.
-
(2011)
J Am Coll Cardiol
, vol.58
, pp. 820-828
-
-
Rajendra, N.S.1
Ireland, S.2
George, J.3
-
52
-
-
0023906357
-
Responses of coronary arteries of cardiac transplant patients to acetylcholine
-
Fish ED, Nable EG, Selwyn AP, et al. Responses of coronary arteries of cardiac transplant patients to acetylcholine. J Clin Invest. 1988;81:21-31. (Pubitemid 18092228)
-
(1988)
Journal of Clinical Investigation
, vol.81
, Issue.1
, pp. 21-31
-
-
Fish, R.D.1
Nabel, E.G.2
Selwyn, A.P.3
Ludmer, P.L.4
Mudge, G.H.5
Kirshenbaum, J.M.6
Schoen, F.J.7
Alexander, R.W.8
Ganz, P.9
-
53
-
-
0033900011
-
Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure
-
Ferdinandy P, Danial H, Ambrus I, et al. Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res. 2000;87:241-247. (Pubitemid 30626433)
-
(2000)
Circulation Research
, vol.87
, Issue.3
, pp. 241-247
-
-
Ferdinandy, P.1
Danial, H.2
Ambrus, I.3
Rothery, R.A.4
Schulz, R.5
-
55
-
-
0035856508
-
Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy
-
Cappola TP, Kass DA, Nelson GS, et al. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 2001;104:2407-2411. (Pubitemid 33108372)
-
(2001)
Circulation
, vol.104
, Issue.20
, pp. 2407-2411
-
-
Cappola, T.P.1
Kass, D.A.2
Nelson, G.S.3
Berger, R.D.4
Rosas, G.O.5
Kobeissi, Z.A.6
Marban, E.7
Hare, J.M.8
-
56
-
-
33846379499
-
Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure
-
DOI 10.1016/j.ijcard.2005.10.033, PII S0167527306003664
-
Jankowska EA, Ponikowska B, Majda J, et al. Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure. Int J Cardiol. 2007;115:151-155. (Pubitemid 46136516)
-
(2007)
International Journal of Cardiology
, vol.115
, Issue.2
, pp. 151-155
-
-
Jankowska, E.A.1
Ponikowska, B.2
Majda, J.3
Zymlinski, R.4
Trzaska, M.5
Reczuch, K.6
Borodulin-Nadzieja, L.7
Banasiak, W.8
Ponikowski, P.9
-
57
-
-
33745503474
-
Hyperuricemia associated with high cardiac event rates in the elderly with chronic heart failure
-
Niizeki T, Takeishi Y, Arimoto T, et al. Hyperuricemia associated with high cardiac event rates in the elderly with chronic heart failure. J Cardiol 2006;47:219-228. (Pubitemid 46940514)
-
(2006)
Journal of Cardiology
, vol.47
, Issue.5
, pp. 219-228
-
-
Niizeki, T.1
Takeishi, Y.2
Arimoto, T.3
Okuyama, H.4
Nozaki, N.5
Hirono, O.6
Tsunoda, Y.7
Watanabe, T.8
Nitobe, J.9
Miyashita, T.10
Takahashi, H.11
Koyama, Y.12
Kubota, I.13
-
58
-
-
0037461111
-
Uric acid and survival in chronic heart: Failure validation and application in metabolic, functional, and hemodynamic staging
-
DOI 10.1161/01.CIR.0000065637.10517.A0
-
Anker SD, Doehner W, Rauchhaus M, et al. Uric acid and survival in chronic heart failure: Validation and application in metabolic, functional, and hemodynamic staging. Circulation. 2003;107:1991-1997. (Pubitemid 36506072)
-
(2003)
Circulation
, vol.107
, Issue.15
, pp. 1991-1997
-
-
Anker, S.D.1
Doehner, W.2
Rauchhaus, M.3
Sharma, R.4
Francis, D.5
Knosalla, C.6
Davos, C.H.7
Cicoira, M.8
Shamim, W.9
Kemp, M.10
Segal, R.11
Osterziel, K.J.12
Leyva, F.13
Hetzer, R.14
Ponikowski, P.15
Coats, A.J.S.16
-
59
-
-
0032402381
-
Uric acid in chronic heart failure: A marker of chronic inflammation
-
DOI 10.1053/euhj.1998.1188
-
Leyva F, Anker SD, Godsland IF, et al. Uric acid in chronic heart failure: A marker of chronic inflammation. Eur Heart J. 1998;19:1814-1822. (Pubitemid 28556651)
-
(1998)
European Heart Journal
, vol.19
, Issue.12
, pp. 1814-1822
-
-
Leyva, F.1
Anker, S.D.2
Godsland, I.F.3
Teixeira, M.4
Hellewell, P.G.5
Kox, W.J.6
Poole-Wilson, P.A.7
Coats, A.J.S.8
-
60
-
-
0025819380
-
Oxygen free radicals and congestive heart failure
-
Belch JJ, Bridges AB, Scott N, et al. Oxygen free radicals and congestive heart failure. Br Heart J. 1991;65:245-248.
-
(1991)
Br Heart J.
, vol.65
, pp. 245-248
-
-
Belch, J.J.1
Bridges, A.B.2
Scott, N.3
-
61
-
-
0024384119
-
Effect of oxygen free radicals on cardiovascular function at organ and cellular levels
-
DOI 10.1016/0002-8703(89)90396-7
-
Prasad K, Kalra J, Chan WP, et al. Effect of oxygen free radicals on cardiovascular function at organ and cellular levels. Am Heart J. 1989;117 1196-1202. (Pubitemid 19150746)
-
(1989)
American Heart Journal
, vol.117
, Issue.6
, pp. 1196-1202
-
-
Prasad, C.1
Kalra, J.2
Chan, W.P.3
Chaudhary, A.K.4
-
62
-
-
77955442528
-
Gout, allopurinol use, and heart failure outcomes
-
Thanassoulis G, Brophy JM, Richard H, Pilote L. Gout, allopurinol use, and heart failure outcomes. Arch Intern Med. 2010;170:1358-1364.
-
(2010)
Arch Intern Med.
, vol.170
, pp. 1358-1364
-
-
Thanassoulis, G.1
Brophy, J.M.2
Richard, H.3
Pilote, L.4
-
63
-
-
34447543603
-
-
American Heart Association. Available at
-
"Heart Attack and Angina Statistics" American Heart Association. Available at: Http://americanheart.org/presenter.jhtml?identifier- 4591.
-
Heart Attack and Angina Statistics
-
-
-
64
-
-
49449114628
-
Effect of PCI on quality of life in patients with stable coronary disease
-
Weintraub W, Spertus J, Kolm P, et al. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med. 2008;359:677-687.
-
(2008)
N Engl J Med.
, vol.359
, pp. 677-687
-
-
Weintraub, W.1
Spertus, J.2
Kolm, P.3
-
65
-
-
5344274543
-
Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk
-
DOI 10.1016/j.amjcard.2004.06.032, PII S000291490400949X
-
Mercuro G, Vitale C, Cerquetani E, et al. Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol. 2004;94:932-935. (Pubitemid 39349561)
-
(2004)
American Journal of Cardiology
, vol.94
, Issue.7
, pp. 932-935
-
-
Mercuro, G.1
Vitale, C.2
Cerquetani, E.3
Zoncu, S.4
Deidda, M.5
Fini, M.6
Rosano, G.M.C.7
-
66
-
-
26044463720
-
Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease
-
DOI 10.1016/j.freeradbiomed.2005.06.004, PII S0891584905003473
-
Baldus S, Koster R, Chumley P, et al. Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease. Free Radic Biol Med. 2005;39:1184-1190. (Pubitemid 41407712)
-
(2005)
Free Radical Biology and Medicine
, vol.39
, Issue.9
, pp. 1184-1190
-
-
Baldus, S.1
Koster, R.2
Chumley, P.3
Heitzer, T.4
Rudolph, V.5
Ostad, M.A.6
Warnholtz, A.7
Staude, H.-J.8
Thuneke, F.9
Koss, K.10
Berger, J.11
Meinertz, T.12
Freeman, B.A.13
Munzel, T.14
-
67
-
-
0027325965
-
Effects of allopurinol on uric acid metabolism and lipid peroxidation in ischemic heart disease patients with stable angina [in Russian]
-
Kaliakin IE, Mit'kin AF. Effects of allopurinol on uric acid metabolism and lipid peroxidation in ischemic heart disease patients with stable angina [in Russian]. Kardiologiia. 1993;33:15-17.
-
(1993)
Kardiologiia.
, vol.33
, pp. 15-17
-
-
Kaliakin, I.E.1
Mit'kin, A.F.2
-
68
-
-
0029052164
-
Reduction of reperfusion injury of human myocardium by allopurinol: A clinical study
-
Gimpel JA, Lahpor JR, van der Molen AJ, et al. Reduction of reperfusion injury of human myocardium by allopurinol: A clinical study. Free Radic Biol Med. 1995;19:251-255.
-
(1995)
Free Radic Biol Med.
, vol.19
, pp. 251-255
-
-
Gimpel, J.A.1
Lahpor, J.R.2
Van Der Molen, A.J.3
-
69
-
-
0023543595
-
Limitation of infarct size for 24 hours by combined treatment with allopurinol plus verapamil during acute myocardial infarction in the dog
-
Kingma JG Jr, Denniss AR, Hearse DJ, et al. Limitation of infarct size for 24 hours by combined treatment with allopurinol plus verapamil during acute myocardial infarction in the dog. Circulation. 1987;75:V25-V33.
-
(1987)
Circulation.
, vol.75
-
-
Kingma Jr., J.G.1
Denniss, A.R.2
Hearse, D.J.3
-
70
-
-
0023855030
-
Prevention of free radical-induced myocardial injury by allopurinol. Experimental study in cardiac preservation and transplantation
-
Bando K, Tago M, Teramoto S. Prevention of free radical-induced myocardial injury by allopurinol. Experimental study in cardiac preservation and transplantation. J Thorac Cardiovasc Surg. 1988;95:465-473. (Pubitemid 18085185)
-
(1988)
Journal of Thoracic and Cardiovascular Surgery
, vol.95
, Issue.3
, pp. 465-473
-
-
Bando, K.1
Tago, M.2
Teramoto, S.3
-
72
-
-
0037047080
-
Allopurinol and endothelial function in heart failure: Future or fantasy?
-
DOI 10.1161/01.CIR.0000024270.37833.F9
-
Landmesser U, Drexler H. Allopurinol and endothelial function in heart failure: Future or fantasy? Circulation. 2002;106:173-175. (Pubitemid 34761294)
-
(2002)
Circulation
, vol.106
, Issue.2
, pp. 173-175
-
-
Landmesser, U.1
Drexler, H.2
-
73
-
-
12444266765
-
Effect of allopurinol pretreatment on free radical generation after primary coronary angioplasty for acute myocardial infarction
-
DOI 10.1097/00005344-200305000-00005
-
Guan W, Osanai T, Kamada T, et al. Effect of allopurinol pretreatment on free radical generation after primary coronary angioplasty for acute myocardial infarction. J Cardiovasc Pharmacol. 2003;41:699-705. (Pubitemid 36523171)
-
(2003)
Journal of Cardiovascular Pharmacology
, vol.41
, Issue.5
, pp. 699-705
-
-
Guan, W.1
Osanai, T.2
Kamada, T.3
Hanada, H.4
Ishizaka, H.5
Onodera, H.6
Iwasa, A.7
Fujita, N.8
Kudo, S.9
Ohkubo, T.10
Okumura, K.11
-
74
-
-
78650001127
-
The prognostic impact of allopurinol in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
-
Rentoukas E, Tsarouhas K, Tsitsimpikou C, et al. The prognostic impact of allopurinol in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Int J Cardiol. 2010;145:257-258.
-
(2010)
Int J Cardiol.
, vol.145
, pp. 257-258
-
-
Rentoukas, E.1
Tsarouhas, K.2
Tsitsimpikou, C.3
-
75
-
-
0033520357
-
Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure
-
Ekelund UE, Harrison RW, Shokek O, et al. Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure. Circ Res. 1999;85:437-445. (Pubitemid 29409620)
-
(1999)
Circulation Research
, vol.85
, Issue.5
, pp. 437-445
-
-
Ekelund, U.E.G.1
Harrison, R.W.2
Shokek, O.3
Thakkar, R.N.4
Tunin, R.S.5
Senzaki, H.6
Kass, D.A.7
Marban, E.8
Hare, J.M.9
-
76
-
-
23644437342
-
Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure
-
DOI 10.1016/j.yjmcc.2005.04.008, PII S0022282805001513
-
Amado LC, Saliaris AP, Raju SV, et al. Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure. J Mol Cell Cardiol. 2005;39:531-536. (Pubitemid 41133738)
-
(2005)
Journal of Molecular and Cellular Cardiology
, vol.39
, Issue.3
, pp. 531-536
-
-
Amado, L.C.1
Saliaris, A.P.2
Raju, S.V.Y.3
Lehrke, S.4
St. John, M.5
Xie, J.6
Stewart, G.7
Fitton, T.8
Minhas, K.M.9
Brawn, J.10
Hare, J.M.11
-
77
-
-
78649380645
-
Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure
-
Wu AH, Ghali JK, Neuberg GW, et al. Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure. Am Heart J. 2010;160:928-933.
-
(2010)
Am Heart J.
, vol.160
, pp. 928-933
-
-
Wu, A.H.1
Ghali, J.K.2
Neuberg, G.W.3
-
78
-
-
23644454293
-
Transient reduction in myocardial free oxygen radical levels is involved in the improved cardiac function and structure after long-term allopurinol treatment initiated in established chronic heart failure
-
DOI 10.1093/eurheartj/ehi305
-
Mellin V, Isabelle M, Oudot A, et al. Transient reduction in myocardial free oxygen radical levels is involved in the improved cardiac function and structure after long-term allopurinol treatment initiated in established chronic heart failure. Eur Heart J. 2005;26:1544-1550. (Pubitemid 41373497)
-
(2005)
European Heart Journal
, vol.26
, Issue.15
, pp. 1544-1550
-
-
Mellin, V.1
Isabelle, M.2
Oudot, A.3
Vergely-Vandriesse, C.4
Monteil, C.5
Di Meglio, B.6
Henry, J.P.7
Dautreaux, B.8
Rochette, L.9
Thuillez, C.10
Mulder, P.11
-
79
-
-
0037024270
-
Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: Results from 2 placebo-controlled studies
-
DOI 10.1161/01.CIR.0000017502.58595.ED
-
Doehner W, Schoene N, Rauchhaus M, et al. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: Results from 2 placebo controlled studies. Circulation. 2002;105:2619-2624. (Pubitemid 34596038)
-
(2002)
Circulation
, vol.105
, Issue.22
, pp. 2619-2624
-
-
Doehner, W.1
Schoene, N.2
Rauchhaus, M.3
Leyva-Leon, F.4
Pavitt, D.V.5
Reaveley, D.A.6
Schuler, G.7
Coats, A.J.S.8
Anker, S.D.9
Hambrecht, R.10
-
80
-
-
0020133458
-
Alterations in vasomotor tone in congestive heart failure
-
Zelis R, Flaim SF. Alterations in vasomotor tone in congestive heart failure. Prog Cardiovasc Dis. 1982;24:437-459.
-
(1982)
Prog Cardiovasc Dis.
, vol.24
, pp. 437-459
-
-
Zelis, R.1
Flaim, S.F.2
-
81
-
-
0031025867
-
The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure
-
Anker SD, Swan JW, Volterrani M, et al. The influence of muscle mass, strength, fatiguability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. Eur Heart J. 1997;18:259-269. (Pubitemid 27107588)
-
(1997)
European Heart Journal
, vol.18
, Issue.2
, pp. 259-269
-
-
Anker, S.D.1
Swan, J.W.2
Volterrani, M.3
Chua, T.P.4
Clark, A.L.5
Poole-Wilson, P.A.6
Coats, A.J.S.7
-
82
-
-
33845447368
-
High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid
-
DOI 10.1161/CIRCULATIONAHA.106.651117, PII 0000301720061205000014
-
George J, Carr E, Davies J, et al. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation. 2006;114:2508-2516. (Pubitemid 44901524)
-
(2006)
Circulation
, vol.114
, Issue.23
, pp. 2508-2516
-
-
George, J.1
Carr, E.2
Davies, J.3
Belch, J.J.F.4
Struthers, A.5
-
83
-
-
20044381182
-
Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure
-
DOI 10.1136/hrt.2004.040477
-
Gavin AD, Struthers AD. Allopurinol reduces type B type natriuretic peptides and hemoglobin but does not alter energy capacity in chronic heart failure. Heart. 2005;91:749-753. (Pubitemid 40769216)
-
(2005)
Heart
, vol.91
, Issue.6
, pp. 749-753
-
-
Gavin, A.D.1
Struthers, A.D.2
-
84
-
-
0036180824
-
Effect of allopurinol on mortality and hospitalisations in chronic heart failure: A retrospective cohort study
-
Struthers AD, Donnan PT, Lindsay P, et al. Effect of allopurinol on mortality and hospitalisations in chronic heart failure: A retrospective cohort study. Heart. 2002;87:229-234. (Pubitemid 34177675)
-
(2002)
Heart
, vol.87
, Issue.3
, pp. 229-234
-
-
Struthers, A.D.1
Donnan, P.T.2
Lindsay, P.3
McNaughton, D.4
Broomhall, J.5
MacDonald, T.M.6
-
85
-
-
0024342857
-
Cyclosporine-induced hyperuricemia and gout
-
Lin HY, Rocher LL, McQuillan MA, et al. Cyclosporine-induced hyperuricemia and gout. N Engl J Med. 1989;321:287-292. (Pubitemid 19193803)
-
(1989)
New England Journal of Medicine
, vol.321
, Issue.5
, pp. 287-292
-
-
Lin, H.-Y.1
Rocher, L.L.2
McQuillan, M.A.3
Schmaltz, S.4
Palella, T.D.5
Fox, I.H.6
-
86
-
-
44649122196
-
Impact of Oxypurinol in Patients With Symptomatic Heart Failure. Results of the OPT-CHF Study
-
DOI 10.1016/j.jacc.2008.01.068, PII S073510970801139X
-
Hare JM, Mangal B, Brown J, et al. OPT-CHF Investigators. Impact of oxypurinol in patients with symptomatic heart failure: Results of the OPTCHF study. J Am Coll Cardiol. 2008;51:2301-2309. (Pubitemid 351783365)
-
(2008)
Journal of the American College of Cardiology
, vol.51
, Issue.24
, pp. 2301-2309
-
-
Hare, J.M.1
Mangal, B.2
Brown, J.3
Fisher Jr., C.4
Freudenberger, R.5
Colucci, W.S.6
Mann, D.L.7
Liu, P.8
Givertz, M.M.9
Schwarz, R.P.10
-
87
-
-
33748116331
-
The Effect of Xanthine Oxidase Inhibition Upon Ejection Fraction in Heart Failure Patients: La Plata Study
-
DOI 10.1016/j.cardfail.2006.05.005, PII S1071916406002557
-
Cingolani HE, Plastino JA, Escudero EM, et al. The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata study. J Card Fail. 2006;12:491-498. (Pubitemid 44307706)
-
(2006)
Journal of Cardiac Failure
, vol.12
, Issue.7
, pp. 491-498
-
-
Cingolani, H.E.1
Plastino, J.A.2
Escudero, E.M.3
Mangal, B.4
Brown, J.5
Perez, N.G.6
-
88
-
-
0030584230
-
Drug therapy. The management of gout
-
Emmerson BT. Drug therapy. The management of gout. N Engl J Med. 1996;334:445-451.
-
(1996)
N Engl J Med.
, vol.334
, pp. 445-451
-
-
Emmerson, B.T.1
-
89
-
-
79151481493
-
Gout therapeutics: New drugs for an old disease
-
Burns CM, Wortmann RL. Gout therapeutics: New drugs for an old disease. Lancet. 2011;377:165-177.
-
(2011)
Lancet.
, vol.377
, pp. 165-177
-
-
Burns, C.M.1
Wortmann, R.L.2
|